Treatment Registry
TR-0770 ActiveRecorded September 2, 2026

Compounded tirzepatide

Sold by Dr.Arevitalize · Injection, vial · every compounded tirzepatide record

What you actually pay

Per month

$269

Medication · Starting price, 12-month bundle$269

Added from the figures recorded below.

Price

TermPer monthCharged today
Starting price, 12-month bundle

Starting at $269/mo with 12 month bundle

source

Per month$269Charged today$269
Visit Dr.Arevitalize

We earn nothing from this link. Dr.Arevitalize has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

StatesAll 50 states
PrescriberBoth
Cancellation“No, there are no long-term commitments. Our flexible plans and transparent pricing let you choose the care that's right for you, with full control at every step.”

Not yet checked: pharmacy, membership and consult fee.

Recorded from drarevitalize.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026The fetcher's SPA excuse was correct about the mechanism (the page really is client-rendered and shows a bare 'LOADING' placeholder before hydration) but wrong about the conclusion — after the render wait, the full storefront, FAQ and all four GLP-1 products with prices are visible. Both an injectable and an oral capsule product line exist for the same drug names; the 4th product ('Semaglutide vs Tirzepatide' — actually 'Tirzepatide Oral Capsules') is recorded under drug=compounded tirzepatide since the page never calls it a brand. Deep links (/pricing, /weight-loss, /glp-1, /legal/terms-of-service) all 404 on direct navigation — this is a client-side-routed app whose sub-routes only resolve when reached by an in-page click, so terms/cancellation detail beyond the homepage FAQ could not be confirmed.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0770
Readings
1

Related records

What else Dr.Arevitalize sells

All Dr.Arevitalize programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Dr.Arevitalize compounded tirzepatide (TR-0770). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0770

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.